For this purpose, we generated subcutaneous allografts in immune-compromised athymic nude mice with above mentioned Palb2-KPC, Brca2-KPC and KPC pancreatic tumor cells and treated tumor-bearing mice with either MMC, or Cisplatin, or vehicle. The gene discussed is BRCA2; the disease is pancreatic neoplasm.